TRxADE Health Inc expected to post a loss of 75 cents a share - Earnings Preview

Scienture Holdings

22/07/2023 03:02

* TRxADE Health Inc  MEDS.OQ   MEDS.O  is expected to show a
fall
in quarterly revenue when it reports  results on July 24
(estimated). 
    * The Lutz Florida-based  company is expected to report  a
33.5% decrease in revenue to $2.18 million from $3.28 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TRxADE Health Inc
is for
a loss of 75 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $12.75​, above​ its last closing price of $8.79. ​​​

This summary was machine generated July 22 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated